Genesis Bioventures

Genesis Bioventures was a life sciences holding company that focused on the development and commercialization of biomedical technologies, primarily in the fields of oncology and diagnostics. The company operated by acquiring and funding subsidiary entities, such as Immuno-Therapeutics and Biovance Technologies, to advance a portfolio of cancer vaccines and diagnostic tools. Its most prominent programs included M-Vax and B-Vax, autologous cell vaccines developed in partnership with Avax Technologies for the treatment of melanoma and breast cancer. Additionally, the company explored diagnostic applications for detecting prion-related diseases like bovine spongiform encephalopathy. Formerly traded on the OTC market, Genesis Bioventures is no longer active in the biotechnology sector.